meteneprost and Obesity

meteneprost has been researched along with Obesity* in 1 studies

Trials

1 trial(s) available for meteneprost and Obesity

Article	Year
Evaluation of meteneprost potassium (a PGE2 analogue) for cervical dilation and side effects in nonpregnant women. Prostaglandins, 1986, Volume: 32, Issue:1 Meteneprost potassium, a PGE2 analogue, was evaluated in thirty non-pregnant women for use as a prospective cervical dilator and softening agent. No significant change in cervical dilation was noted. A significant relationship between obesity and side effects was observed. Topics: 16,16-Dimethylprostaglandin E2; Adult; Aged; Blood Pressure; Body Temperature; Cervix Uteri; Dilatation; Double-Blind Method; Female; Humans; Middle Aged; Obesity; Prospective Studies; Prostaglandins E, Synthetic; Pulse; Respiration; Suppositories	1986

Article

Year

Evaluation of meteneprost potassium (a PGE2 analogue) for cervical dilation and side effects in nonpregnant women.

Prostaglandins, 1986, Volume: 32, Issue:1

Meteneprost potassium, a PGE2 analogue, was evaluated in thirty non-pregnant women for use as a prospective cervical dilator and softening agent. No significant change in cervical dilation was noted. A significant relationship between obesity and side effects was observed.

Topics: 16,16-Dimethylprostaglandin E2; Adult; Aged; Blood Pressure; Body Temperature; Cervix Uteri; Dilatation; Double-Blind Method; Female; Humans; Middle Aged; Obesity; Prospective Studies; Prostaglandins E, Synthetic; Pulse; Respiration; Suppositories

1986